Bicycle Therapeutics plc Retained Earnings
Bicycle Therapeutics plc (BCYC) had Retained Earnings of -$1.01 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-30
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.01B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$960.58M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$899.75M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$879.60M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$1.01B 10-Q · filed 2026-07-30 |
| 2026-03-31 | -$960.58M 10-Q · filed 2026-04-30 |
| 2025-12-31 | -$899.75M 10-Q · filed 2026-07-30 |
| 2025-09-30 | -$879.60M 10-Q · filed 2025-10-30 |
| 2025-06-30 | -$820.50M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$741.54M 10-Q · filed 2025-05-01 |
| 2024-12-31 | -$680.79M 10-K · filed 2026-03-17 |
| 2024-09-30 | -$628.94M 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$578.13M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$538.32M 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$511.76M 10-K · filed 2025-02-25 |
| 2023-09-30 | -$462.66M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$412.76M 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$370.16M 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$331.10M 10-K · filed 2024-02-20 |
| 2022-09-30 | -$301.12M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$272.77M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$245.94M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$218.38M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$200.34M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$185.66M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$167.75M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$151.56M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$134.13M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$123.99M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$111.87M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$100.55M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$96.14M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$86.66M 10-Q · filed 2019-08-08 |
| 2018-12-31 | -$69.94M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |